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ABSTRACT 
 
The Multiple Antibiotic Resistance Regulator Family (MarR) are 
transcriptional regulators, many of which forms a dimer. Transcriptional regulation 
provides bacteria a stabilized responding system to ensure the bacteria is able to 
efficiently adapt to different environmental conditions. The main function of the 
MarR family is to create multiple antibiotic resistance from a mutated protein; this 
process occurs when the MarR regulates an operon. We hypothesized that different 
transcriptional regulator genes have interactions with each other. It is known that 
Salmonella pagC transcription is activated by three regulators, i.e., SlyA, MprA, and 
PhoP. Bacterial Adenylate Cyclase-based Two-Hybrid (BACTH) system was used to 
research the protein-protein interactions in SlyA, MprA, and PhoP as heterodimers 
and homodimers in vivo. Two fragments, T25 and T18, that lack endogenous 
adenylate cyclase activity, were used for construction of chimeric proteins and 
reconstruction of adenylate cyclase activity was tested. The significant adenylate 
cyclase activities has proved that SlyA is able to form homodimers. However, weak 
adenylate cyclase activities in this study has proved that MprA and PhoP are not 
likely to form homodimers, and no protein-protein interactions were detected in 
between SlyA, MprA and PhoP, which no heterodimers have formed in between three 
transcriptional regulators. 
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CHAPTER 1 
INTRODUCTION 
Due to the wide range of environmental conditions bacteria have to be able to 
efficiently adapt to their changing environment. It is vital for the cell’s survival to be 
able to monitor the changes that occur around it: such as, pH, temperature, 
concentrations of toxic substrates, and osmotic activity (1). This is commonly 
accomplished using the two-component system. The two-component signal 
transduction occurs when a stimulus is received and passed to a response regulator in 
order to adapt to the environmental changes (2). This two-component signal 
transduction often involves a histidine protein kinase, which is later transferred to an 
aspartate residue after the regulator protein has taken action (3). The transmembrane 
proteins channel takes the input from the stimulus to the intracellular responses that 
adapt to it (1). 
 Protein-protein interactions play an important role in the cells ability to adapt 
to its environment (4). Currently, research is being done in order to further understand 
the protein-protein interactions that occur in living organisms. These protein-protein 
interactions are being analyzed and recorded in order to create the ultimate interaction 
map known as the interactome map (4). 
MarR Family 
 Multiple Antibiotic Resistance Regulator family (MarR) is known as a 
transcriptional regulator, which plays an important role in molecular biology. MarR 
family is found in Escherichia coli and many other species. The process of the 
transcriptional regulation is to transcript DNA to RNA in order to maintain the cell’s 
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gene activities (5). When MarR family regulates an operon, a multiple antibiotic 
resistance is created from a mutated protein The MarR family is primarily in charge of 
controlling antibiotic efflux pumps as well as the expression of genes (7) and the 
regulation of metabolic enzymes (5). This specific class of transcriptional regulators 
function primarily by controlling an operon that affects the drug efflux pumps (8). 
The operon encodes the efflux pumps which are then responsible for transporting and 
eliminating toxic substances.  
  Efflux pumps are transport proteins, present in microorganisms (9), that are 
responsible for the elimination of toxic substances. Their job is so find toxic 
substrates within the cell and transport them into the external environment (8). These 
pumps were first observed in Escherichia coli (9). Efflux pumps are not only able to 
transport toxins outside of the cell, but they also have mechanisms that allow them to 
lower antibiotic concentration and also enhance mutation accumulation (10). 
Antibiotic resistance can be accomplished by either decreasing the targets affinity for 
binding to the antibiotic, or by decreasing the concentration of the antibiotic that is 
present within the cell (9). 
 There are five major efflux transporters: major facilitator (MF), multidrug and 
toxic efflux (MATE), resistance-nodulation-division (RND), small multi-drug 
resistance (SMR), and ATP binding cassette (ABC) (8). These transporters can be 
associated with antibiotic resistance when over-expression occurs. This over-
expression can occur with the activation of a transcriptional regulator such as MarA 
(8).  Over-expression of multidrug efflux pumps has been linked to drug resistance 
(10). This is due to the cells ability to withstand and survive antibiotic pressure (8). 
Along with this, the cells are able to develop more mutations in the target site related 
genes (8).  
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 When MarR family regulates an operon, a multiple antibiotic resistance is 
created from a mutated protein (5). The MarR family also controls mutations in 
certain proteins that lead to multiple antibiotic resistance (5). Antibiotic resistance is 
described as an antibiotics inability to reach its microbial target (9). This class of 
transcriptional regulators are commonly found within organisms showcasing a larger 
genome size. The larger the genome size the more MarR homologs can be found 
within that system. MarR homologs are abundantly found in free-living, complex 
organisms rather than organisms containing a reduced genome size. They are not 
found in abundance within organisms found in restricted niches or those who have a 
small genome size (7). Their presence within the system has shown to play a key role 
in allowing an organism to adapt to its changing environment.  
 The ability to adapt to a changing environment comes generally from the 
MarR family’s capability to regulate gene expression. These transcriptional regulators 
function by repressing gene activity. Uncommonly, some MarR homologs have 
shown a potential to activate transcription, although most do not. Gene expression is 
most commonly regulated through several ways. It can either be regulated physically 
through ligand binding or chemically through the oxidation of specific cysteines (5). 
A conformational change occurs when the ligand bind resulting the attenuation of 
DNA (7). Ligand binding competes with RNA polymerase resulting in an obstruction 
that does not allow for transcriptional elongation to occur (5).  
 Transcription will shut of as the concentration of the MarR homologs 
increases. As the concentration of MarR decreases then transcription will increase. 
The nature of this mechanism allows for a more sensitive response to the binding of 
the ligands (5). 
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The MarR family of transcriptional regulators demonstrate an interesting 
structure that facilitates their gene regulation. The MarR family of transcriptional 
regulators display a winged helix-turn-helix (wHTH) DNA-binding domain (7). As 
shown in figure 1. They exist as dimers that commonly bind to palindromic sequences 
(5), as shown in figure 1. These palindromic sequences reside in cognate promoters 
(7). DNA-binding affinity is controlled by the interlock of the amino- and carboxy- 
terminal helices that determines the distance between the DNA recognition helices 
(5).  
 
Figure 1: MarR family transcriptional regulator structure and SlyA dimer structure. 
Left illustrated above is the winged helix-turn-helix (wHTH) DNA- binding domain 
that is characteristic of the MarR family of transcriptional regulators (7). These 
transcriptional regulators exist as dimers that bind to palindromic sequences that 
reside in cognate promoters (5). The illustrated above in the right image is the SlyA 
dimer structure. The SlyA dimer binds to palindromic sequences as shown in the 
structure (27). 
SlyA 
 SlyA is a MarR family transcriptional regulator belonging to the 
Enterobacteriaceae family (11). It was originally observed in Salmonella typhimurium 
where it was identified to be a key element for the survival of the bacteria in 
macrophages (12) as well as for the resistance to oxidative stress within bacteria (13). 
slyA has also been found to be a contributing factor in the regulation of certain PhoP-
dependent genes (13). 
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In Escherichia coli slyA is used for the expression of a cryptic hemolysin (12) 
as well as cryptic cytolysin (6). More than 130 slyA homologs have been found in 
both bacteria and archaea (14). slyA has the same crystal structure and wHTH DNA-
binding as the rest of the MarR family (15).  
Proteins that derive from the MarR/SlyA family are responsible for expressing 
virulence genes (15). slyA also plays a key role in changing the cell surface in order to 
protect the cell from toxic compounds that the host produces (6). The regulation of 
slyA occurs through promoter occlusion (6). This allows slyA to be a gene that 
represses its own expression (6). As shown in figure 2. 
 
Figure 2: Activation and Repression of MarR/SlyA family transcriptional regulators. 
A. MarR/SlyA family competes with a repressor binding on the promoter to allow a 
transcription. B. MarR/SlyA family enabling an activator and competes with a 
repressor binding on the promoter to allow a transcription. C. MarR/SlyA family 
excludes RNAP and binds to the promoter. D.MarR/SlyA family competes with an 
activator protein on binding, excludes RNAP and prevents the transcription. Image is 
modified from the Regulation of virulence by members of the MarR/SlyA family. 
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MprA 
 MprA is a transcriptional regulator that shares a c-terminal wHTH DNA-
binding structure with the rest of the MarR family (16). The mprA gene is responsible 
for controlling the expression of various Escherichia coli genes (17).  
When transcribed the increase of the MprA serves as a regulatory mechanism 
for some genes. When increased it inhibits MccC7 production but blocks proU 
osmoinduction (17). The MprA is produced when during the stationary phase (18). 
mprA contains two recognition motifs that when bound illustrate important thymine 
residues (19). Further research needs to be conducted to determine the function of 
proteins encoded by mprA-dependent genes (19). 
PhoP 
 PhoP is a transcriptional regulator found in Salmonella (20). This particular 
gene works commonly in a two-component system to provide resistance to different 
antimicrobial peptides (21). The two-component system that PhoP is a potent 
regulator that is able to perform diverse actions within the cell. It allows Salmonella 
to produce a lethal infection (tested in mice), adapt to conditions where Mg(2+) are 
provided, and create resistance to an array of antimicrobial peptides (22).  
 This transcription regulator works alongside SlyA to control gene expression. 
Specifically, in the expression of slyA itself; where SlyA is the repressor and PhoP is 
the activator of SlyA (6). The two-component system of the PhoP transcriptional 
regulator has shown to enhance resistance of both E. coli and Salmonella to toxic 
substances (23). 
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Protein-Protein Interaction 
 Proteins are important in living organism and cells because they control 
biological activity. Some proteins are independently, which include their only 
functions. However, most proteins control biological systems by interacting with 
other proteins. There are different type of protein interactions includes Protein-DNA 
Interaction, Protein-RNA Interaction, Protein-Cofactor Interaction, Protein-Ligand 
Interaction and Protein-Protein Interaction.   
 Protein-Protein Interaction is defined by physical contacts between two or 
more protein molecules that occur in vivo level, including living organism and cells 
(4). Protein-Protein interaction only occurs when two or more proteins interact 
together directly (24). However, functional interactions shouldn’t be considered as 
Protein-Protein interaction because those functional interactions widely exist in living 
organisms, and includes interactions between genes, protein, and metabolites. Protein-
Protein Interaction can be separated into two different types, stable interactions and 
transient interaction, both can be strong or weak. Common experimental methods to 
research Protein-Protein Interactions are co-immunoprecipitation, Pull-down assays, 
Far-western blot analysis, and Two-Hybrid Screening. 
Co-Immunoprecipitation 
 Co-Immunoprecipitation is a straightforward and rapid method to detect 
protein-protein interactions. This method identifies protein-protein interactions when 
the interactions are stable and strong. As shown in figure 3. Co-Immunoprecipitation 
uses target protein-specific antibodies to locate and identify proteins that are bound 
with the target protein. This method located physiologically relevant interactions that 
are bound to the target protein. As shown in figure 3. 
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Figure 3: Principle of Co-immunoprecipitation (co-IP). A. A protein mixture was 
prepared. B. The protein mixture was incubated with Antibody-coupled Resin. The 
immune complex is then precipitated. An antibody-binding protein is immobilized. C. 
Purified Antibody-binding protein was eluted and analyzed by sodium dodecyl 
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). Image was modified from 
Thermofisher Scientific. 
Pull-down assays 
 Pull-down assay is a method commonly used to detect the physical interaction 
of two or more proteins in vitro. Pull-down assay is similar to Co-
Immunoprecipitation. However, rather than using antibodies, the pull-down assay 
uses bait proteins to capture the proteins. This method is another form of affinity 
purification that involves affinity chromatography. Affinity chromatography is used in 
Pull-down assay to shorten the time for purifying proteins. As shown in figure 4. 
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Figure 4: The principle of Pull-down assay. A. The fusion-tagged bait protein from 
the lysate was immobilized with an affinity ligand. B. The immobilized bait protein 
was bound with prey protein. C. Protein-Protein interaction complex was eluted and 
analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). 
Image was modified from Thermofisher Scientific. 
Far-Western Blot 
 Far-Western blot is a direct method to analyze protein-protein interaction by 
using tagged bait proteins and prey proteins. These proteins separated through gel 
electrophoresis, at which point a protein-protein interaction can be detected. Far-
Western blot allows the study of protein-protein interactions processed without using 
antigen-specific antibodies. As shown in figure 5. 
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Figure 5: The principle of Far-western blot analysis. A. Prey proteins were separated 
by gel electrophoresis and interacts with tagged bait protein. B. Enzyme (HRP) with 
antibody was targeted on the bait tag of bait protein for labeling the 
interaction. radiolabeled bait protein that is detected by exposure to film. Image was 
modified from Thermofisher Scientific. 
Two-Hybrid Screening   
 Two-Hybrid Screening is an accessible method to most labs without 
sophisticated equipment to provide a direct way to detect and research protein-protein 
interactions in vivo. The principle of Two-Hybrid Screening is to detect physical 
interactions between proteins, that protein-protein interactions can be discovered 
though this method. As shown in figure 6.  
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Figure 6: The principle of Two-Hybrid Screening. A. Gal4 transcriptional factor gene 
produces two domain proteins (BD and AD). Those proteins are essential for the 
transcription of the reporter gene (lacZ). B. A fusion protein Bait with Bal4BD were 
prepared and the transcription of reporter gene (lacZ) was not activated. C. A fusion 
protein Prey with Bal4AD were prepared and the transcription of reporter gene (lacZ) 
was not activated. D. Transcription of the reporter gene (lacZ) occurred when 
Gal4BD+Bait interacts with Gal4AD+Prey. Image was modified from the BACTH 
system user manual. 
 
Bacterial Adenylate Cyclase Two-Hybrid (BACTH) System 
 The focus of this paper is to explore the protein-protein interactions of two 
hybrid proteins with the same recipient bacteria Escherichia coli DHM1 cells. This is 
done by using the BACTH system kit. The four fragments were pKT25, pKNT25 
(both of which contained the kanamycin resistance gene), pUT18, and pUT18c (both 
of which contained the ampicillin resistance gene). 
Bacterial Adenylate Cyclase Two-Hybrid (BACTH) System is a scientific 
system used to detect protein-protein interactions in Escherichia coli by using 
bacterial adenylate cyclase in vivo. Plasmids that carry T25 (pKT25 and pKNT25) or 
T18 (pUT18 and pUT18C) fragments were used to combine as fusions with three 
transcriptional regulator genes (slyA, mprA and phoP), due to different antibiotic 
resistances (Ampicillin resistance on T18 fragment and Kanamycin resistance on T25 
fragment), to detect the co-expression of proteins in those transcriptional regulators. 
The reporter strain DHM1 that carries both T18 and T25 fragments can be grown on 
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selection plates with X-Gal. The X-Gal selection plates were used to detect the 
expression of lacZ if adenylate cyclase was activated. By running the β-galactosidase 
enzymatic activities assay, the interaction between those proteins can also be detected. 
As shown in figure 7.  
 
Figure 7: Shown above is the BACTH system that was used over the course of the 
experiment. A. Catalytic domain of adenylate cyclase (CyaA) from Bordetella 
pertussis combines two complementary fragments, T25 and T18. B. By separating 
two complementary fragments, T25 and T18 are not active. C. Two complementary 
fragments (T25 and T18) are used to interact with two polypeptides (X and Y). A 
functional complementation occurs due to the two protein interactions between two 
fragments. D. cAMP (Cyclic AMP) was produced and binds to the CAP (Catabolite 
Activator Protein). The cAMP/CAP complex regulator of gene transcription in 
Escherichia coli. Image was modified from the BACTH system user manual. 
Plasmids 
 The catalytic domain of adenylate cyclase (CyaA) from Bordetella pertussis 
combines two complementary fragments (T25 and T18) that fused with two proteins 
that interacted with each other (Gouzei K, 1998). cAMP was produced when two-
hybrid proteins interact with each other, which cause the functional complementation 
between two complementary fragments (T25 and T18). Transcription of catabolic 
operons was activated when cAMP binds with the CAP, which forms characteristic 
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phenotypes. Four plasmids that carry T25 fragment (pKT25 and pKNT25) or T18 
fragment (pUT18 and pUT18C) were used and either N or C-termini on both 
fragments allow genetic fusions due to protein interactions.  
  As a derivative of plasmid pSU40, plasmid pKT25 produces a kanamycin 
resistance. It was also known that plasmid pKT25 carries a complementary fragment 
T25. When lac promoter controlled by transcription, T25 fragment was expressed. By 
inserting a multicloning site sequence (MCS) to the 3’ end of T25, the in-frame 
genetic fusion can be constructed at the C-terminal end of the T25 polypeptide. 
 plasmid pKNT25 is also a derivative of plasmid pSU40, which express a 
kanamycin resistance. By inserting a multicloning site sequence (MCS) to the 5’ end 
of the T25, the in-frame genetic fusion can be constructed at the N-terminal end of the 
T25 polypeptide. 
 plasmid pUT18 produces an ampicillin resistance because it is a derivative of 
plasmid pUT19. plasmid pUT18 carries a complementary fragment T18. When lac 
promoter controlled by transcription, T18 fragment was expressed. By inserting a 
multicloning site sequence (MCS) to the 5’ end of T18, the in-frame genetic fusion 
can be constructed at the N-terminal end of the T18 polypeptide. 
 Similar to plasmid pUT18, the plasmid pUT18C is also a derivative of plasmid 
pUT19, which express the ampicillin resistance. plasmid pUT18C also carries the T18 
complementary fragment. By inserting a multicloning site sequence (MCS) to the 3’ 
end of the T18, the in-frame genetic fusion can be constructed at the N-terminal end 
of the T18 polypeptide. As shown in figure 8. 
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Figure 8: Plasmid maps of pKT25, pKNT25, pUT18, and pUT18C. Image was 
modified from the BACTH system user manual. 
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CHAPTER 2 
MATERIALS AND METHODS 
Cloning Vectors and Genes 
Four distinct plasmids carrying T25 (pKT25 and pKNT25) and T18 (pUT18 
and pUT18C) fragments were used in this experiment to ligase with three 
transcriptional regulator genes (slyA, mprA, phoP). These plasmids allow for protein-
protein interaction in both N-terminal and C-terminal on both T25 and T18 fragments. 
The pKT-Zip and pUT-Zip plasmids were used as a positive control after combining 
them into the reporter strain DHM1.  Negative controls for this experiment were 
dependent on different combinations, which used only one transcriptional regulator 
gene that had been ligated with one of the plasmid and combined with another 
plasmid carrying fragments without a gene combination.  
SlyA, MprA and PhoP are three transcriptional regulators in MarR family. 
Their genes were used to ligate the four plasmids (pKT25, pKNT25, pUT18, and 
pUT18C) by using the technology of molecular cloning to research the protein-protein 
interactions between each other.  
Polymerase Chain Reaction (PCR) and Gene Purification 
Polymerase Chain Reaction (PCR) is a technology that widely used in 
molecular biology. The advantage of PCR is the ability to amplify and test genes in 
vivo rather than testing it in a live organism. Three transcriptional regulator genes 
(slyA, mprA, and phoP) were amplified by using PCR, as shown in Table 1. After the 
PCR, those three amplified genes were run using a 1% 0.5X TBE agarose gel with the 
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amount of 2uL. This was done to check for fragment size under UV light. Products 
with positive results were purified using 0.1X volume of 3M NaAC and 2X volume of 
100% pure ethanol into -20oC freezer for 15 minutes. After incubation they were each 
centrifuged, and the pellet was washed with 70% ethanol, and resuspended by TE.   
Table 1: The PCR Reaction System and Program Settings. 
PCR Reaction System PCR Program 
Reagents Amount Name Temperature Time 
5X PCR Buffer 20μL Initialization 94°C 5mins 
gDNA 2μL Denaturation 94°C 30s 
25mM dNTP 
(with MgCl2) 
0.8μL Annealing X°C 30s 
Forward Primer 0.2μL Elongation 72°C 40s-1min 
(Back to 
Denaturation 
with 34 cycles 
total) 
Reverse Primer 0.2μL Final 
Elongation 
72°C 7mins 
DNA Taq 
Polymerase 
3.33μL Final Hold 4°C Indefinite 
Distilled Water up to 100μL 
 
   
Phenol Alkaline Plasmid Isolation 
Plasmids were isolated by using Phenol Alkaline. Pellets containing the 
plasmids were resuspended with GTE solution with lysozyme, reacted with 
NaOH/SDS solution, and they were incubated in an ice bath after the addition of KaC 
solution. Phenol was used to extract the proteins, and chloroform was added to 
remove the phenol from the solution. Later, products were purified using 2X volume 
  17 
of 100% pure ethanol with 0.1X volume of 3M NaAC and placed into the -20oC 
freezer for 15 minutes. After incubation the products were centrifuged, and the pellets 
were washed with 70% ethanol, and then resuspended by TE with RNASE.  
DNA Isolation 
In restriction digest, restriction enzyme work as molecular scissors that cut 
DNA on specific restriction sites. The restriction enzyme KpnI (BioLabs), was used to 
digest four DNA vectors (pKT25, pKNT25, pUT18, and pUT18C). Three target PCR 
products (slyA, mprA, and phoP) were incubated in 37oC for 3 hours to produce 
cohesive ends, as shown in Table 2. All digestion products were run through an 
agarose gel (concentration of 1% 0.5X TBE) in order to check the fragment size under 
UV light. Positive results were extracted from the gel and purified using OMEGA 
E.Z.N.A Gel Extraction Kit. After which, 1μg of vector DNAs and 3μg of insert 
DNAs were ligated together. Creating a solution with a total volume of 10μL includes 
2μL 5X ligation Buffer and 0. 5μL T4 Ligase (5 Weiss U/μL). Nuclease-free water 
was used to bring the total volume up to 10μL if necessary. As shown in Table 3. The 
reaction was kept at room temperature overnight.  
Competent cells (Top10) were washed using autoclaved water and 15% 
glycerol and stocked with 15% glycerol. Then, 10μL of ligation products were mixed 
with 200μL, and incubated on the ice bath for 30 minutes. After which, a 90s heat 
shock was conducted in 42oC. After a 3-minute incubation period on the ice bath, a 
500μL LB broth was added into the mixture and incubated for 1 hour in 37oC shaker. 
When the incubation concluded, a 150μL culture was streaked on LB plates with 
either Kanamycin or Ampicillin antibiotics (50 µg/mL Kanamycin or 50 µg/mL 
Ampicillin). These plates were incubated at 37oC for 12-15 hours.  
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Table 2: Restriction Digest Reaction 
Restriction Digest Reaction System 
Reagents Amount 
10X Digest Buffer 5μL 
Vector DNAs or PCR produts 1μg 
KpnI 0.5μL 
Distilled Water up to 50μL 
Table 3: Ligation Reaction 
Ligation Reaction System 
Reagents Amount 
5X Ligation Buffer 2μL 
Insert DNAs 3μg 
Vector DNAs 1μg 
T4 Ligase 0.5μL 
Distilled Water up to 10μL 
Confirmations 
Colonies were selected and streaked on LB plates with either Kanamycin or 
Ampicillin antibiotics. Isolated single colonies were used to run the ID-PCR as a 
confirmation for identification of the correct fragment insert. Single colonies (8 
isolated colonies/DNA) were added into a 10μL (total volume) mixture combined 
with 5X PCR Buffer, 25mM dNTP with MgCl2, forward primer, reverse primer, 
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DNA Taq Polymerase and distilled water, as shown in Table 4. After the PCR, all 
samples were pipetted into the 1% 0.5X TBE agarose gel for 30 mins. By using the 
UV light, clear binds showed up as positive results, which confirmed that the insert 
DNAs (slyA, mprA, phoP) were successfully inserted into the vector DNAs (pKT25, 
pKNT25, pUT18, pUT18C). 
Table 4: ID-PCR Reaction System and Program Settings 
PCR Reaction System (8 
  isolated colonies/DNA) 
PCR Program 
Reagents Amount Name Temperatur
e 
Time 
5X PCR 
  Buffer 
16μL Initializatio
n 
94°C 5mins 
25mM 
  dNTP (with 
MgCl2) 
0.64μL Denaturatio
n 
94°C 30s 
Forward 
  Primer 
0.16μL Annealing X°C 30s 
  Elongation 72°C 40s-1min 
Reverse 
  Primer 
0.16μL (Back 
  to 
Denaturati
on with 34 
cycles 
total) 
DNA 
  Taq Polymerse 
2.67μL Final 
Elongation 
72°C 7mins 
Distilled 
  Water 
up to 80μL Final Hold 4°C Indefinite 
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Colonies that were used as templates in the ID-PCR reaction were re-
inoculated in 5 mL LB broth with either Kanamycin or Ampicillin antibiotics (50 
µg/mL Kanamycin or 50 µg/mL Ampicillin) overnight in a 37oC shaker. Overnight 
cultures were used to isolate plasmids by using the phenol alkaline plasmid isolation 
method. After that, isolated plasmid DNAs were used in ID-Digestion with KpnI 
(BioLabs) as a restriction enzyme, as shown in Table 5. A 20μL mixture containing 
10X Digest Buffer, plasmid DNAs, KpnI and distilled water were placed on a 37oC 
water bath for 2 hours. Then, the digestion products were run onto a 1% 0.5X TBE 
agarose gel to check positive results. Plasmids that showed positive results were sent 
to a sequencing lab for a professional and thorough sequencing analysis.  
Table 5: Restriction Digest Reaction 
restriction digest reaction system 
Reagents Amount 
10X Digest Buffer 2μL 
Plasmids 10μL 
KpnI 0.2μL 
Distilled Water up to 20μL 
 
Two-hybrid Screening and β-galactosidase Enzymatic Activities Assay 
lacZ is a marker gene that is commonly used in gene expression and 
regulation. When two transcriptional regulators work together to activate lacZ gene, 
then β-galactosidase is encoded. X-Gal (5-bromo-4-chloro-3-indolyl-β-D- 
galactopyranoside) is a substrate of β-galactosidase.  When β-galactosidase is 
encoded, X-Gal yields a blue color in affected colonies. IPTG acts as an inducer, it 
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induces the β-galactosidase to function more efficiently. After the plasmid DNAs, 
carrying the T25 and T18 fragments, had settled as a combination, and had been 
inserted into the reporter strain DHM1, by using electric shock, transformation 
products were streaked on LB plates with both Kanamycin and Ampicillin antibiotics 
(50 µg/mL Kanamycin,50 µg/mL Ampicillin) at 37oC. After the overnight 
inoculation, colonies were re-streaked on LB plates containing both Kanamycin and 
Ampicillin antibiotics, IPTG, and X-Gal (50 µg/mL Kanamycin,50 µg/mL 
Ampicillin) as a screening test. Positive results yielded the blue color on colonies. 
Colonies were inoculated into 1 mL LB broth contained both Kanamycin and 
Ampicillin antibiotics (50 µg/mL Kanamycin,50 µg/mL Ampicillin) on a 37oC shaker 
overnight. From the overnight cultures, 12 μL were re-inoculated into 600 μL LB 
broth contained IPTG, Kanamycin and Ampicillin antibiotics (0.5 M IPTG, 50 µg/mL 
Kanamycin,50 µg/mL Ampicillin). β-galactosidase enzymatic activities assay was run 
at different times during the incubation (4 hours, 12 hours, 24 hours, and 48 hours) to 
test the protein-protein interaction.  
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CHAPTER 3 
RESULTS 
PCR Reactions and Plasmid Isolation 
PCR reactions were used to amplified three transcriptional regulator genes 
(slyA, mprA, and phoP). A total of 35 cycles of denaturation, annealing, and 
elongation were repeated in the PCR reaction. After the PCR reaction concluded, 
amplified genes were running on agarose gel. slyA, mprA, and phoP showed positive 
results due to the comparable sizes of the experimental bands and the theoretical.  
Four plasmids (pKT25, pKNT25, pUT18, pUT18C) were isolated by using the 
method of phenol alkaline plasmid isolation. The products were run on agarose gel 
and all plasmids showed positive results that matched their expected sizes. As shown 
in figure 9. 
     L                             L                        1         2        3       4                      L     5    6 
 
Figure 9: PCR results of slyA, mprA, and phoP. Three DNAs were amplified by PCR 
reaction. PCR product were run onto the 1% 0.5X agarose gel. L=100bp DNA 
Ladder, 1,2=slyA (441bp), 3,4=mprA (531bp), and 5,6=phoP (675bp). All DNAs 
showed strong bands on the gel and were matched with published gene sizes. 
Restriction Digest 
PCR products were purified and resuspend in TE solution. All plasmids and 
PCR products were digested by using KpnI. It was confirmed that all amplified DNAs 
and plasmid DNAs have only one restriction site. For this reason, the result showed 
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only one clear bind that matched the size of each DNAs that acted as the true positive 
result. After the reaction, all digestion products were run on the 1% 0.5X agarose gel 
for 30mins. The result has showed that all digestion products were positive with their 
expected size. As shown in figure 10 and figure 11. 
        L                         L            1           2           3            4            5           6           7 
 
Figure 10: Restriction digest result of pKT25, pKNT25, pUT18, and pUT18C. Four 
plasmid DNAs were well digested by using KpnI. Digestion products were run on the 
1% 0.5X agarose gel. L=Lambda DNA/Hind III Marker ladder, 1,2= pKNT25 
(3469bp), 3,4,5= pKT25 (3442bp), 6=pUT18 (3023bp), 7= pUT18C (3017bp). All 
plasmid DNAs showed strong bands on the gel and were matched with published 
plasmid DNA sizes 
  L                                 L        1         2          3       4                         L         5          6               
 
Figure 11: Restriction digest result of slyA, mprA, and phoP. Three DNAs were well 
digested by KpnI. Digestion products were run on the 1% 0.5X agarose gel. L= 100bp 
DNA Ladder, 1,2=mprA (531bp), 3,4=slyA (441bp), and 5,6=phoP (675bp).  All 
DNAs showed strong bands on the gel and were matched with published gene sizes. 
Confirmation 
Plasmids were used as vector DNAs and were ligated with purified PCR 
products. After the transformation, vector DNAs were successfully ligated with insert 
DNAs and inserted in to the Top10 recipient cells to form colonies. Colonies were 
picked and streak on plates to form single isolated colonies. Four single colonies were 
used as a template in ID-PCR reaction to test the target DNAs. A strong positive 
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result confirmed that the target DNAs (slyA, mprA, phoP) were ligated with four 
plasmid DNAs (pKT25, pKNT25, pUT18, pUT18C). As shown in figure 12-fugure 
15. 
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Figure 12: ID-PCR results of pKT25-mprA, pKNT25-mprA, pUT18-mprA, and 
pUT18C-mprA. The ID-PCR of mprA gene was ligated on four plasmid DNAs 
(pKT25, pKNT25, pUT18, pUT18C). After the PCR reaction, ID-PCR products were 
run on the 1% 0.5X agarose gel. L= 100bp DNA Ladder, 1=pKT25-mprA (1299bp), 
2=pKNT25-mprA (648bp), 3,4,5,6=pUT18-mprA (648bp), and 7=pUT18C-mprA 
(1170bp). All DNAs matched the theoretical sizes with strong bands. 
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Figure 13: ID-PCR results of pKT25-slyA, pKNT25-slyA, pUT18-slyA, and pUT18C-
slyA. The ID-PCR of slyA gene was ligated on four plasmid DNAs (pKT25, pKNT25, 
pUT18, pUT18C). After the PCR reaction, ID-PCR products were run on the 1% 
0.5X agarose gel. L= 100bp DNA Ladder, 1,2,3,4=pKT25-slyA (1209bp), 
5,6,7,8=pKNT25-slyA (558bp), 9,10,11=pUT18-slyA (558bp), and 12=pUT18C-slyA 
(1080bp). All DNAs matched the theoretical sizes with strong bands. 
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Figure 14: ID-PCR results of pKT25-phoP, pKNT25-phoP, pUT18-phoP, and 
pUT18C-phoP. The ID-PCR of phoP gene was ligated on four plasmid DNAs 
(pKT25, pKNT25, pUT18, pUT18C). After the PCR reaction, ID-PCR products were 
run on the 1% 0.5X agarose gel. L= 100bp DNA Ladder, 1,2,3=pKT25- phoP 
(1443bp), 4,5=pKNT25- phoP (792bp), 6=pUT18- phoP (792bp), and 
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7,8,9=pUT18C- phoP (1314bp). All DNAs matched the theoretical sizes with strong 
bands. 
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Figure 15: ID-Digestion results. Three DNAs that ligated on four plasmid DNAs 
(pKT25, pKNT25, pUT18, pUT18C) were well digested by KpnI. Digestion products 
were run on the 1% 0.5X agarose gel. L= 100bp DNA Ladder, 1= pUT18 (3023bp) 
and mprA (531bp), 2= pUT18C (3017bp) and mprA (531bp), 3= pUT18C (3017bp) 
and slyA (441bp), 4= pKT25 (3442bp) and slyA (441bp), 5= pKT25 (3442bp) and 
mprA (531bp), 6= pKNT25 (3469bp) and slyA (441bp), 7= pUT18 (3023bp) and slyA 
(441bp), 8= pKT25 (3442bp) and phoP (675bp), 9= pKNT25 (3469bp) and phoP 
(675bp), 10= pKNT25 (3469bp) and mprA (531bp), 11= pUT18 (3023bp) and phoP 
(675bp), 12= pUT18C (3017bp) and phoP (675bp). All DNAs matched the published 
sizes with strong bands. 
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Gene Sequencing 
Plasmids that demonstrated positive results on both ID-PCR and ID-Digestion 
were sent to the sequence lab for a detailed comparison with sequences existing 
within the database. Results showed no differences between all nucleotide sequences 
and published sequences. Therefore, all insert DNAs were successfully ligated on 
target plasmid DNAs and were used on the two-hybrid screening. As shown in figure 
16-figure 27. The β-galactosidase enzymatic activities assay was conducted by getting 
two-hybrid combinations from the transformation. 
 
Figure 16: pKT25-slyA sequencing result. The alignment between pKT25-slyA gene 
sequencing result and published slyA gene. 
 
Figure 17: pKNT25-slyA sequencing result. The alignment between pKNT25-slyA 
gene sequencing result and published slyA gene. 
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Figure 18: pUT18-slyA sequencing result. The alignment between pUT18-slyA gene 
sequencing result and published slyA gene. 
 
Figure 19: pUT18C-slyA sequencing result. The alignment between pUT18C-slyA 
gene sequencing result and published slyA gene. 
 
 
 
Figure 20: pKT25-mprA sequencing result. The alignment between pKT25-mprA 
gene sequencing result and published mprA gene. 
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Figure 21: pKNT25-mprA sequencing result. The alignment between pKNT25-mprA 
gene sequencing result and published mprA gene. 
 
Figure 22: pUT18-mprA sequencing result. The alignment between pUT18-mprA 
gene sequencing result and published mprA gene. 
 
Figure 23: pUT18C-mprA sequencing result. The alignment between pUT18C-mprA 
gene sequencing result and published mprA gene. 
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Figure 24: pKT25-phoP sequencing result. The alignment between pKT25-phoP gene 
sequencing result and published phoP gene. 
 
Figure 25: pKNT25-phoP sequencing result. The alignment between pKNT25-phoP 
gene sequencing result and published phoP gene. 
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Figure 26: pUT18-phoP sequencing result. The alignment between pUT18-phoP gene 
sequencing result and published phoP gene. 
 
Figure 27: pUT18C-phoP sequencing result. The alignment between pUT18C-phoP 
gene sequencing result and published phoP gene. 
Two-hybrid Screening and β-galactosidase Enzymatic Activities Assay 
After comparing the sequencing results and verifying that the target DNAs 
were successfully ligated on plasmid DNAs, all new built plasmids with target DNAs 
were transformed into reporter stain DHM1. Plasmids with either T25 or T18 
fragments included target DNAs were transformed together in DHM1, then inoculated 
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on plates with X-Gal in order to test the protein-protein interactions between the 
transcriptional regulator genes. Positive results showed a colony color change, from 
white to blue. The lacZ marker gene expression in Escherichia coli is activated due to 
the interaction between proteins. X-Gal acts as a substrate of β-galactosidase and 
allows the colonies to undergo the color change.  
Negative controls were made by inserting an empty plasmid (T25 or T18 
fragments) and a plasmid with DNAs inserted carries another antibiotic resistance into 
the reporter strain DHM1. With only one transcriptional regulator gene, there’s no 
proteins interacted. Positive controls were made by the combination of pKT-Zip and 
pUT-Zip.  
 By comparing results with negative controls, pKT25-slyA pUT18-slyA, 
pKT25-slyA pUT18C-slyA, and pKNT25-slyA pUT18-slyA yielded positive results 
with the blue color of colonies on X-Gal screening plates after a 40 hours incubation 
at 30oC. As shown in figure 28. Other combinations yielded negative result, meaning 
no protein-protein interaction occurred. As shown in figure 29-figure 33. 
 
Figure 28: The X-gal screening assay of slyA combinations. The two-hybrid 
combination of slyA and itself (pKT25-slyA pUT18-slyA, pKT25-slyA pUT18C-slyA, 
pKNT25-slyA pUT18-slyA, pKNT25-slyA pUT18C-slyA) were streaked with their 
negative controls (pKT25-slyA pUT18, pKT25 pUT18C-slyA, pKNT25 pUT18-slyA, 
pKNT25-slyA pUT18C) and a positive control (pKT-Zip pUT-Zip). pKT-Zip pUT-
Zip, pKT25-slyA pUT18C-slyA, pKNT25-slyA pUT18-slyA and pKNT25-slyA 
pUT18C-slyA formed blue color colonies. 
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Figure 29: The X-gal screening assay of mprA combinations. The two-hybrid 
combination of mprA and itself (pKT25-mprA pUT18-mprA, pKT25-mprA pUT18C-
mprA, pKNT25-mprA pUT18-mprA, pKNT25-mprA pUT18C-mprA) were streaked 
with their negative controls (pKT25-mprA pUT18, pKT25 pUT18C-mprA, pKNT25 
pUT18-mprA, pKNT25-mprA pUT18C) and a positive control (pKT-Zip pUT-Zip). 
pKT-Zip pUT-Zip formed blue color colonies. 
 
Figure 30: The X-gal screening assay of phoP combinations. The two-hybrid 
combination of phoP and itself (pKT25-phoP pUT18-phoP, pKT25-phoP pUT18C-
phoP, pKNT25-phoP pUT18-phoP, pKNT25-phoP pUT18C-phoP) were streaked 
with their negative controls (pKT25-phoP pUT18, pKT25-phoP pUT18C, pKNT25-
phoP pUT18, pKNT25-phoP pUT18C) and a positive control (pKT-Zip pUT-Zip). 
pKT-Zip pUT-Zip formed blue color colonies. 
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Figure 31: The X-gal screening assay of mprA and slyA combinations. The two-hybrid 
combination of mprA and slyA (pKT25-mprA pUT18-slyA, pKT25-mprA pUT18C-
slyA, pKNT25-mprA pUT18-slyA, pKNT25-mprA pUT18C-slyA, pKT25-slyA 
pUT18-mprA, pKT25-slyA pUT18C-mprA, pKNT25-slyA pUT18-mprA, pKNT25-
slyA pUT18C-mprA) were streaked with their negative controls (pKT25-mprA 
pUT18, pKT25 pUT18C-slyA, pKNT25 pUT18-slyA, pKNT25-mprA 
pUT18C,pKT25-slyA pUT18, pKT25 pUT18C-mprA, pKNT25 pUT18-mprA, and 
pKNT25-slyA pUT18C) and a positive control(pKT-Zip pUT-Zip). pKT-Zip pUT-Zip 
formed blue color colonies. 
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Figure 32: The X-gal screening assay of phoP and slyA combinations. The two-hybrid 
combination of phoP and slyA (pUT18-slyA pKT25-phoP, pUT18-slyA pKNT25-
phoP, pUT18C-slyA pKT25-phoP, pUT18C-slyA pKNT25-phoP, pKT25- slyA 
pUT18- phoP, pKT25-slyA pUT18C-phoP, pKNT25-slyA pUT18-phoP, and 
pKNT25-slyA pUT18C-phoP,) were streaked with their negative controls (pUT18-
slyA pKT25, pUT18-slyA pKNT25, pUT18C-slyA pKT25, pUT18C-slyA pKNT25, 
pKT25-slyA pUT18, pKT25-slyA pUT18C, pKNT25-slyA pUT18, and pKNT25-slyA 
pUT18C) and a positive control (pKT-Zip pUT-Zip). pKT-Zip pUT-Zip formed blue 
color colonies. 
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Figure 33: The X-gal screening assay of phoP and mprA combinations. The two-
hybrid combination of phoP and mprA (pUT18-phoP pKT25-mprA, pUT18-phoP 
pKNT25-mprA, pUT18C-phoP pKT25-mprA, pUT18C-phoP pKNT25-mprA, 
pKT25-phoP pUT18-mprA, pKT25-phoP pUT18C-mprA, pKNT25-phoP pUT18-
mprA, and pKNT25-phoP pUT18C-mprA,) were streaked with their negative controls 
(pUT18 pKT25-mprA, pUT18-phoP pKNT25, pUT18C-phoP pKT25, pUT18C 
pKNT25-mprA, pKT25-phoP pUT18, pKT25-phoP pUT18C, pKNT25-phoP pUT18, 
and pKNT25-phoP pUT18C) and a positive control (pKT-Zip pUT-Zip). pKT-Zip 
pUT-Zip formed blue color colonies 
Results confirmed that blue colonies with the combination of pKT25-slyA 
pUT18-slyA, pKT25-slyA pUT18C-slyA, and pKNT25-slyA pUT18-slyA on X-Gal 
plates had activated adenylate cyclase, lacZ gene was expressed, so blue colonies 
were yielded when β-galactosidase was encoded. As shown in figure 34 and figure 35. 
Colonies from plates were used to inoculate into LB broth. After the 24-hour 
re-inoculation, cultures were used on a β-galactosidase enzymatic activities assay. By 
comparing results of β-galactosidase enzymatic activities between different 
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combinations and their negative controls, a significant difference (at least 2-time 
difference) of β-galactosidase enzymatic activities were observed between the 
combination of pKT25-slyA pUT18-slyA, pKT25-slyA pUT18C-slyA, and pKNT25-
slyA pUT18-slyA and its negative control. No significant differences on β-
galactosidase enzymatic activities detected between SlyA and MprA, SlyA and PhoP, 
MprA and PhoP, also SlyA with itself and MprA with itself. As shown in figure 45. 
 
 
Figure 34: β-galactosidase enzymatic activities assay of SlyA. The β-galactosidase 
activities of SlyA and itself were detected and compared with negative controls and 
the positive control. pKT25-slyA pUT18-slyA, pKT25-slyA pUT18C-slyA, and 
pKNT25-slyA pUT18-slyA had stronger β-galactosidase activities comparison with 
their negative controls. 
0
500
1000
1500
2000
2500
3000
3500
4000
4500
β
-g
al
ac
to
si
d
as
e 
ac
ti
v
it
y
(M
il
le
r 
U
n
it
)
  37 
 
Figure 35: β-galactosidase enzymatic activities assay of SlyA without positive 
control. The β-galactosidase activities of SlyA and itself were detected and compared 
with negative controls. pKT25-slyA pUT18-slyA, pKT25-slyA pUT18C-slyA, and 
pKNT25-slyA pUT18-slyA had stronger β-galactosidase activities comparison with 
their negative controls. 
 
 
Figure 36: β-galactosidase enzymatic activities assay of MprA. The β-galactosidase 
activities of MprA were detected and compared with negative controls and the 
positive control. MprA didn’t have a significant difference on β-galactosidase 
activities. 
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Figure 37: β-galactosidase enzymatic activities assay of MprA without positive 
control. The β-galactosidase activities of MprA were detected and compared with 
negative controls and the positive control. MprA didn’t have a significant difference 
on β-galactosidase activities. 
 
Figure 38: β-galactosidase enzymatic activities assay of PhoP. The β-galactosidase 
activities of PhoP were detected and compared with negative controls and the positive 
control. PhoP didn’t have a significant difference on β-galactosidase activities. 
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Figure 39: β-galactosidase enzymatic activities assay of PhoP without positive 
control. The β-galactosidase activities of PhoP were detected and compared with 
negative controls and the positive control. PhoP didn’t have a significant difference 
on β-galactosidase activities. 
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Figure 40: β-galactosidase enzymatic activities assay of SlyA and MprA. The β-
galactosidase activities of SlyA and MprA were detected and compared with negative 
controls and the positive control. SlyA and MprA didn’t have a significant difference 
on β-galactosidase activities. 
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Figure 41: β-galactosidase enzymatic activities assay of SlyA and MprA without 
positive control. The β-galactosidase activities of SlyA and MprA were detected and 
compared with negative controls and the positive control. SlyA and MprA didn’t have 
a significant difference on β-galactosidase activities. 
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Figure 42: β-galactosidase enzymatic activities assay of PhoP and MprA. The β-
galactosidase activities of PhoP and MprA were detected and compared with negative 
controls and the positive control. PhoP and MprA didn’t have a significant difference 
on β-galactosidase activities. 
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Figure 43: β-galactosidase enzymatic activities assay of PhoP and MprA without 
positive control. The β-galactosidase activities of PhoP and MprA were detected and 
compared with negative controls and the positive control. PhoP and MprA didn’t have 
a significant difference on β-galactosidase activities. 
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Figure 44: β-galactosidase enzymatic activities assay of PhoP and SlyA. The β-
galactosidase activities of PhoP and SlyA were detected and compared with negative 
controls and the positive control. PhoP and SlyA didn’t have a significant difference 
on β-galactosidase activities. 
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Figure 45: β-galactosidase enzymatic activities assay of PhoP and SlyA without 
positive control. The β-galactosidase activities of PhoP and SlyA were detected and 
compared with negative controls and the positive control. PhoP and SlyA didn’t have 
a significant difference on β-galactosidase activities. 
For detecting β-galactosidase enzymatic activities of SlyA base on the 
significant β-galactosidase activities of pKT25-slyA pUT18-slyA, pKT25-slyA 
pUT18C-slyA, and pKNT25-slyA pUT18-slyA combination, another set of β-
galactosidase enzymatic activity assay with the SlyA and itself were ran in four 
different times (4 hours, 12 hours, 24 hours, and 48 hours) to research the different β-
galactosidase enzyme activities in different given times. This is because β-
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galactosidase enzyme activities may perform differently depending on the bacteria 
growth. After a 4-hour incubation, the combination of pKT25-slyA pUT18-slyA 
showed some significant β-galactosidase enzyme activities of more than 2-time 
differences by the comparison of its negative controls. No significant β-galactosidase 
enzyme activities differences were observed in other combinations. As shown in 
figure 46. 
 
Figure 46: β-galactosidase enzymatic activities assay of SlyA with and without 
positive control with 4-hour incubation. The β-galactosidase activities of SlyA and 
itself were detected at 4-hour and compared with negative controls. pKT25-slyA 
pUT18-slyA and pKT25-slyA pUT18C-slyA, had stronger β-galactosidase activities 
comparison with their negative controls. 
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After 12-hour incubation, a 4-time differences of β-galactosidase enzyme 
activities were detected between pKT25-slyA pUT18-slyA and its negative control. 
The β-galactosidase enzyme activities of pKT25-slyA pUT18C-slyA was 11-time 
stronger than the native control. By compare the pKNT25-slyA pUT18-slyA and its 
negative control, a 2-time difference was observed. pKNT25-slyA pUT18C-slyA had a 
3-time stronger β-galactosidase enzyme activity by compare with its negative 
controls. As shown in figure 47. 
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Figure 47: β-galactosidase enzymatic activities assay of SlyA with and without 
positive control with 12-hour incubation. The β-galactosidase activities of SlyA and 
itself were detected at 12-hour and compared with negative controls. pKT25-slyA 
pUT18-slyA had 4 times stronger β-galactosidase activities comparison with their 
negative controls. pKT25-slyA pUT18C-slyA had 11 times stronger β-galactosidase 
activities comparison with their negative controls. 
After 24-hour incubation, a 5-time differences of β-galactosidase enzyme 
activities were detected between pKT25-slyA pUT18-slyA and its negative control. 
The β-galactosidase enzyme activities of pKT25-slyA pUT18C-slyA was 11-time 
stronger than the native control. By compare the pKNT25-slyA pUT18-slyA and its 
negative control, a 2-time difference was observed. pKNT25-slyA pUT18C-slyA had a 
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3-time stronger β-galactosidase enzyme activity by compare with its negative 
controls. As shown in figure 48. 
 
Figure 48: β-galactosidase enzymatic activities assay of SlyA with and without 
positive control with 24-hour incubation. The β-galactosidase activities of SlyA and 
itself were detected at 24-hour and compared with negative controls. pKT25-slyA 
pUT18-slyA had 5 times stronger β-galactosidase activities comparison with their 
negative controls. pKT25-slyA pUT18C-slyA had 11 times stronger β-galactosidase 
activities comparison with their negative controls. pKNT25-slyA pUT18-slyA had 2 
times stronger β-galactosidase activities comparison with their negative controls. 
pKNT25-slyA pUT18C-slyA had 3 times stronger β-galactosidase activities 
comparison with their negative controls. 
After 48-hour incubation, a 5-time differences of β-galactosidase enzyme 
activities were detected between pKT25-slyA pUT18-slyA and its negative control. 
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The β-galactosidase enzyme activities of pKT25-slyA pUT18C-slyA was 11-time 
stronger than the native control. By compare the pKNT25-slyA pUT18-slyA and its 
negative control, a 2-time difference was observed. pKNT25-slyA pUT18C-slyA had a 
3-time stronger β-galactosidase enzyme activity by compare with its negative 
controls. As shown in figure 49. 
 
Figure 49: β-galactosidase enzymatic activities assay of SlyA with and without 
positive control with 48-hour incubation. The β-galactosidase activities of SlyA and 
itself were detected at 48-hour and compared with negative controls. pKT25-slyA 
pUT18-slyA had 5 times stronger β-galactosidase activities comparison with their 
negative controls. pKT25-slyA pUT18C-slyA had 11 times stronger β-galactosidase 
activities comparison with their negative controls. pKNT25-slyA pUT18-slyA had 2 
times stronger β-galactosidase activities comparison with their negative controls. 
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pKNT25-slyA pUT18C-slyA had 3 times stronger β-galactosidase activities 
comparison with their negative controls. 
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CHAPTER 4 
DISCUSSION 
 Gene Isolation 
Three genes (slyA, mprA, and phoP) were used and successfully amplified 
through the PCR reaction. Four plasmids (pKT25, pKNT25, pUT18, and pUT18C) 
were isolated by using phenol alkaline plasmid isolation. After purifying PCR 
products, a successful digestion was made by using KpnI on both PCR products and 
isolated plasmid DNAs. After digested products get purified, insert DNAs were 
successfully ligated with target vector DNAs, positive results were confirmed by ID-
PCR and ID-Digestion. Results of the sequencing check was the last confirmation 
when both ID-PCR and ID-Digestion were positive and matched their expected size.  
While running gel with digestion products, some bands showed strong background 
connected with their bands, which was a strong signal of incomplete digestion. 
Incomplete digestion happens commonly in the process of digestion and it normally 
causes by over or less amount of enzyme in the digestion system, or by unknown 
compounds that amplified due to contaminations.  
It was noticed that some false-positive results were observed on the gel by 
running ID-PCR results. While PCR was in progress, if PCR products weren’t 
purified, or with an inefficient purification, some compounds may affect DNA 
samples, causing DNA degradation, and contaminating DNA samples. DNA 
degradation is critical during the PCR reaction because it strongly affect the DNA 
amplifications. Also, contaminations are possibly to lower the speed of DNA 
amplifications or affect the specificity due to the interaction between primers and 
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DNAs. Those contaminations may produce a lot of artifactual PCR products. When 
running the gel by using such PCR products, false-positive results were observed. 
Two-hybrid screening and β-galactosidase Enzymatic Activities Assay Improvements 
While different two-hybrid combinations (with both T25 and T18 fragments) 
were streaked on X-Gal plates with their negative controls (only one target DNA 
inserted) and positive control pKT-Zip pUT-Zip. After a 40-hour inoculation in a 
30oC incubator, expected color changes were observed. Positive control on every 
plate showed an obvious color change and formed blue color colonies. There was no 
color change observed between the gene combination of slyA with mprA, slyA with 
phoP, mprA with phoP, mprA with mprA, and phoP with phoP. Color change was 
overserved with the combination between slyA and itself.  
  X-Gal is a substrate of β-galactosidase. If adenylate cyclase was activated, 
lacZ gene was expressed, blue colonies were yielded when β-galactosidase was 
encoded. When color change was observed, meaning there were protein-protein 
interaction detected between two transcriptional regulators. Protein-protein interaction 
is a significant signal and it allows organisms respond with different environment to 
adapt in to those changes by using a stimulus-response mechanism. When 
environmental stimulus was detected, histidine kinase sends this signal of stimulus to 
its regulator to active expressions from target genes.  
  False positive results were observed due to an over inoculation. This is 
possibly because of the His+ transformants. Colonies with His+ transformants 
contains hybrid proteins without plasmids encoding. These hybrid proteins sometimes 
interact with their target proteins if colonies were over inoculated, which forms 
another type of protein-protein interaction causing the color change of colonies. 
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Colonies from plates were inoculated for 24 hours in 37 oC for the β-
galactosidase enzymatic activities assay. Results confirmed that the protein-protein 
interactions only happen between SlyA and itself, which pKT25-slyA pUT18-slyA, 
pKT25-slyA pUT18C-slyA, and pKNT25-slyA pUT18-slyA had increased β-
galactosidase activities comparison to their negative controls. For more details on how 
SlyA had protein-protein interactions with itself, another set of β-galactosidase 
enzymatic activities assay were prepared with different inoculation times (4 hours, 12 
hours, 24 hours, and 48 hours). When SlyA combines with itself, β-galactosidase 
activities have increased significantly. After the 4-hour inoculation, the positive 
control combination pKT-Zip pUT-Zip showed a significant increasing value of β-
galactosidase activities. Combinations of pKT25-slyA pUT18-slyA, pKT25-slyA 
pUT18C-slyA, and pKNT25-slyA pUT18-slyA results also showed that β-
galactosidase activities have increased comparison to their negative control 
combinations. β-galactosidase activities after 24-hour incubation were stabilized and 
combinations of SlyA have detected significant changes by comparison with their 
negative controls, meaning the protein interactions were detected. 
Positive results were observed from the β-galactosidase enzymatic activities 
assay on slyA combinations, but different combination formed different β-
galactosidase enzymatic activities. The reason causes these differences is due to the 
different position that slyA ligated on four different plasmids (pKT25, pKNT25, 
pUT18, and pUT18C). Genetic fusions occur on either N-termini or C-termini to 
allow protein interactions. On plasmid pKT25, the slyA was ligated at the 5’ end of 
the complementary fragment T25. When slyA was ligated on the plasmid pKNT25, 
the slyA was inserted onto the 3’ end of fragment T25. Similar to plasmid pKT25, 
slyA was ligated on the 5’ end of fragment T18 that located on the plasmid pUT18C, 
  55 
and 3’ end of fragment T18 on plasmid pUT18C was the position where slyA ligated 
on. Adenylate cyclase domain includes T25 catalytic site and T18 calmodulin binding 
site. That is, when slyA ligated on plasmids with different positions, different β-
galactosidase enzymatic activities are detected. Different combinations confirmed that 
β-galactosidase enzymatic activities were occurred due to protein interactions.   
 It was observed that there were no β-galactosidase enzymatic activities 
detected on the combination of pKNT25-slyA pUT18C-slyA and its negative control 
after the 4-hour inoculation. The probable reason causes this result is the 
concentration of culture wasn’t enough by only 4-hour of incubation.   
Methodology Improvements 
 
 The Bacterial Adenylate Cyclase Two-Hybrid (BACTH) System method were 
used to study the protein-protein interactions. By comparison with other methods used 
on the study of protein interactions, Bacterial Adenylate Cyclase Two-Hybrid 
(BACTH) System doesn’t required sophisticated equipment, which is accessible to 
most microbiology labs. Also, this method is scalable, meaning the screening of the 
protein interactions can be detected among many proteins. Results from the BACTH 
system allows a similar quality by comparison the data that generated by the 
alternative approach of co-affinity purification followed by mass spectrometry. The 
disadvantage by using this method is commonly observed with high number of false 
positive and false negative identification. False identifications are observed when 
unnatural protein concentrations produced by the overexpression of the fusion protein. 
False identifications are also occurring when fused parts from hybrid protein inhibit 
certain interaction causing the inaccurate results. The most common reason to cause 
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the false negative result is when two interacting proteins found to be non-interacting 
when they are not localized to the nucleus.  
 Previous research suggests that two-hybrid system works for the study of both 
homodimers and heterodimers (26). In two-hybrid system, two complementary 
fragments (T25 and T18) need to join in order to initiate cAMP synthesis. By 
separating two fragments, or combining the same fragment, the cAMP cannot be 
produced. The fusion of polypeptides with the fragments causes a functional 
complementation. This only occurs when the fragments are in pairs and are able to 
initiate cAMP production. cAMP binds to the CAP, then cAMP/CAP complex 
regulator of gene transcription occurs in Escherichia coli. 
 Previous study suggests that the transcriptional regulator SlyA can form a 
homodimer (27). In the study, the DSS cross-linking occurred to form the SlyA 
homodimer. The similarity of the results from this study to the two-hybrid screening 
and β-galactosidase enzymatic activities assay, show that the protein interactions in 
SlyA occurred; which supports the statement that SlyA forms a homodimer.  
 According to previous experiment, both PhoP and MprA have been found to 
form homodimers (30) (31). This experiment contradicts to those previous studies 
since, in this case, PhoP and MprA were not found to form homodimers. In protein 
interactions, false-negative results were observed when low level of interactions are 
present. However, Phop and MprA did not result in homodimers for this experiment. 
This difference is most likely a result of a false-negative outcome. Although the 
BATCH system is an efficient method for detecting protein-protein interactions, false-
negatives can still occur. These false-negative results can occur for several reasons. 
The first reason revolves around the expression of lactose operons (29). Both β-
galactosidases and plating on the LB+X-GAL+KM+AMP plates are an indirect 
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measurement of the interactions that occur between the proteins. Low protein-protein 
interactions cannot be accurately measured using these techniques (29). If there were 
low levels of protein-protein interactions, then the color change within the samples 
may not be apparent.  
 Another reason that caused false-negative results was due to the lack of the 
mating and transformation (28). In the process of transformation, if there weren’t 
enough cell numbers for testing two-hybrid combinations, false-negative may be 
presented. 
 Third, when the domain-specific misfolding occurs in some constructs based 
on two-hybrid combinations. Some protein interactions can still be detected, but 
nonfunctional for other interactions. This may cause false-negative results (28). 
 Another possible reason false-negative results were observed may be because 
of disturbances in the proteins during cell reproduction (28). Non-interacting proteins 
may come in contact with an interacting protein causing false-negative results. This is 
due to the weak, or limited, protein reactions caused by non-interacting proteins 
encountering interacting proteins.  Interacting proteins must meet with a protein of its 
same kind in order to produce positive results. 
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CHAPTER 5 
CONCLUSION 
Two-hybrid screening results showed there were protein interactions between 
SlyA and itself. β-galactosidase enzymatic activities assay results have also confirmed 
that SlyA interacted with itself by significant increases of β-galactosidase enzymatic 
activities in two-hybrid combinations comparison with their negative controls. SlyA 
SlyA is able to form homodimers. However, no protein interactions were detected 
between SlyA and MprA, SlyA and PhoP, MprA and PhoP, and MprA, PhoP with 
itself. Therefore, MprA and PhoP couldn’t form homodimers, and no heterodimers 
were form in between three transcriptional regulators. Based on Burbulis and 
Shirley’s research (33), some proteins only interacted with each other in a specific 
way and orientation.    
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